An employee complaint at Eli Lilly's Branchburg plant alleges altered quality control docs amid FDA probe — report
Eli Lilly was one of the earliest players in the race for a Covid-19 antibody, but a series of setbacks at a New Jersey manufacturing …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
